Cargando…
Bisphosphonate Treatment Beyond 5 Years and Hip Fracture Risk in Older Women
IMPORTANCE: Clinical trials have demonstrated the antifracture efficacy of bisphosphonate drugs for the first 3 to 5 years of therapy. However, the efficacy of continuing bisphosphonate for as long as 10 years is uncertain. OBJECTIVE: To examine the association of discontinuing bisphosphonate at stu...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436954/ https://www.ncbi.nlm.nih.gov/pubmed/33284336 http://dx.doi.org/10.1001/jamanetworkopen.2020.25190 |